<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04972734</url>
  </required_header>
  <id_info>
    <org_study_id>RBHP 2021 PONS</org_study_id>
    <nct_id>NCT04972734</nct_id>
  </id_info>
  <brief_title>Cohort of Premature Newborns for Charaterization of the Digestive Microbiota in Ulcerative Necrotizing Enterocolitis in Premature Infants</brief_title>
  <acronym>CortECS</acronym>
  <official_title>Cohort of Premature Newborns for Charaterization of the Digestive Microbiota in Ulcerative Necrotizing Enterocolitis in Premature Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MEDIS Laboratory</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>QUAPA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ENTeRisk</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare the bacterial digestive microbiota during the stay in neonatal intensive care between&#xD;
      a group of premature newborns developing a NEC (necrotizing enterocolitis) and a group of&#xD;
      newborns free from NEC.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Monitoring of a cohort of premature newborns with constitution of a collection of biological&#xD;
      samples.&#xD;
&#xD;
      follow-up of newborns from birth up to 37 weeks of amenorrhea. The medical care of children&#xD;
      will not be affected by their participation in the research.&#xD;
&#xD;
        -  Sampling of amniotic fluid at the time of rupture of the water bag&#xD;
&#xD;
        -  Sampling of the blood contained in the umbilical cord after clamping and section of the&#xD;
           cord&#xD;
&#xD;
        -  Sampling of meconium during the first 24 hours of life in intensive care / neonatal /&#xD;
           maternity ward&#xD;
&#xD;
        -  Collection of a daily stool sample until the end of hospitalization and when a NEC&#xD;
           occurs&#xD;
&#xD;
        -  Sampling of gastric residues during an episode of NEC&#xD;
&#xD;
        -  Taking a daily sample of the newborn's enteral food&#xD;
&#xD;
        -  Sampling of 500 ÂµL of additional blood weekly during the punctures made for the&#xD;
           treatment&#xD;
&#xD;
        -  Daily statement of constants&#xD;
&#xD;
        -  Record of all complications related to prematurity (HIV, bronchodysplastic, sepsis)&#xD;
&#xD;
             -  Blood analysis: CBC, platelets and CRP (data analyzed as part of the treatment).&#xD;
                Specific analyzes for research will assess: the level of tryptase, IL4 and TLR4.&#xD;
                The samples will be stored and analyzed in the immunology laboratory of the CHU&#xD;
                Clermont Ferrand (Pr B. Evrard)&#xD;
&#xD;
             -  Analysis of the meconium sample and each stool emitted during hospitalization, and&#xD;
                during an episode of ECUN&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>comparison of volatolomics results of the gut microbiota</measure>
    <time_frame>Immediatly after the intervention</time_frame>
    <description>Characterization of the gut microbiota using a capture method by hybridization of the gene encoding 16S rRNA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>comparison of microbiological results of the gut microbiota</measure>
    <time_frame>Immediatly after the intervention</time_frame>
    <description>Characterization of the gut microbiota using a capture method by hybridization of the gene encoding 16S rRNA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fungal microbiota</measure>
    <time_frame>Immediatly after the intervention</time_frame>
    <description>Comparison of the fungal microbiota on 10 NECS and 10 healthy babies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tryptasemia</measure>
    <time_frame>Day 1, Day 3, Immediatly after the intervention</time_frame>
    <description>measurement of blood tryptasemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>environmental xenobiotics</measure>
    <time_frame>Day 1</time_frame>
    <description>measurement of titane and silicia levels in placental and meconium assays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Milk protein composition</measure>
    <time_frame>daily for 12 weekd</time_frame>
    <description>milk protein determination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Milk lipid composition</measure>
    <time_frame>daily for 12 weekd</time_frame>
    <description>milk lipid determination</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Necrotizing Enterocolitis</condition>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>NEC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>premature newborns developing a NEC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>premature newborns without NEC</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>premature newborns developing a NEC</intervention_name>
    <description>weekly Blood sample and daily Stools sample during 12 weeks + Blood and stool sample during NEC</description>
    <arm_group_label>NEC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>premature newborns without NEC</intervention_name>
    <description>weekly Blood sample and daily Stools sample during 12 weeks</description>
    <arm_group_label>Healthy control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  born prematurely &lt; 37 weeks of amenorrhea at the maternity ward of the CHU&#xD;
&#xD;
          -  affiliated with a social security regime&#xD;
&#xD;
          -  the holders of parental authority are able to give an informed consent to participate&#xD;
             in the research&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  fetal pathology&#xD;
&#xD;
          -  newborns whose holders of parental authority are under guardianship or under the age&#xD;
             of 18&#xD;
&#xD;
          -  refusal of participation by holders of parental authority&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Minutes</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lise Laclautre</last_name>
    <phone>04 73 75 11 95</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise Laclautre</last_name>
      <phone>04 73 75 11 95</phone>
      <email>promo_interne_drci@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Maguelonne PONS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 28, 2021</study_first_submitted>
  <study_first_submitted_qc>July 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Necrotizing Enterocolitis</keyword>
  <keyword>prematurity</keyword>
  <keyword>volatolomic and microbiological signatures</keyword>
  <keyword>mast cell activation</keyword>
  <keyword>blood tryptase assay</keyword>
  <keyword>fungal digestive colonization</keyword>
  <keyword>fecal calprotectin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

